1 |
van de Schoot AJ, de Boer P, Crama KF, Visser J, Stalpers LJ, Rasch CR, et al. Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer. Acta Oncologica. 2016;55(7):892-9.
DOI
|
2 |
Choi SG. Literature review of clinical usefulness of heavy ion particle as an new advanced cancer therapy. Journal of Radiological Science and Technology. 2019;42(6):413-22.
DOI
|
3 |
Hwang SY, Kim YJ, Lee SW. Evaluation of residual radioactivity and dose rate of a target assembly in an IBA cyclotron. Journal of Radiological Science and Technology. 2016;39(4):643-9.
DOI
|
4 |
Fassbender M, Shubin YN, Lunev V, Qaim S. Experimental studies and nuclear model calculations on the formation of radioactive products in interactions of medium energy protons with copper, zinc and brass: Estimation of collimator activation in proton therapy facilities. Applied Radiation and Isotopes. 1997;48(9):1221-30.
DOI
|
5 |
Baumer C, Backer CM, Gerhardt M, Grusell E, Koska B, Kroninger K, et al. Measurement of absolute activation cross sections from carbon and aluminum for proton therapy. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. 2019;440:75-81.
DOI
|
6 |
Bennett G, Goldberg A, Levine G, Guthy J, Balsamo J, Archambeau J. Beam localization via 15O activation in proton-radiation therapy. Nuclear Instruments and Methods. 1975;125(3):333-8.
DOI
|
7 |
Yan X, Titt U, Koehler A, Newhauser W. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 2002;476(1-2):429-34.
|
8 |
Zheng Y, Newhauser W, Fontenot J, Taddei P, Mohan R. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy. Physics in Medicine & Biology. 2007;52(15):4481.
DOI
|
9 |
Agosteo S, Birattari C, Caravaggio M, Silari M, Tosi G. Secondary neutron and photon dose in proton therapy. Radiotherapy and Oncology. 1998;48(3):293-305.
DOI
|
10 |
Newhauser W, Titt U, Dexheimer D, Yan X, Nill S. Neutron shielding verification measurements and simulations for a 235-MeV proton therapy center. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 2002;476(1-2):80-4.
|
11 |
Battistoni G, Boehlen T, Cerutti F, Chin PW, Esposito LS, Fasso A, et al. Overview of the FLUKA code. Annals of Nuclear Energy. 2015;82:10-8.
DOI
|
12 |
Tuli JK. Evaluated nuclear structure data file. Brookhaven National Laboratory Nuclear Data Center, Brookhaven, NY; 1987.
|
13 |
Aarnio P, Ranft J, Stevenson G, Moehring H, Fasso A, Zazula J, et al. FLUKA: hadronic benchmarks and applications. P00012231; 1993.
|
14 |
Guan F. Design and simulation of a passive-scattering nozzle in proton beam radiotherapy. Texas A & M University; 2010.
|
15 |
Firestone RB, Shirley VS, CD SFC, Baglin CM. Table of Isotopes (A= 263-272). 1996.
|
16 |
Data TID. Technical Report No. 261. Vienna: IaeA. 1986.
|
17 |
Han SE, Cho G, Lee SB. An assessment of the secondary neutron dose in the passive scattering proton beam facility of the national cancer center. Nuclear Engineering and Technology. 2017;49(4):801-9.
DOI
|
18 |
Lundkvist J, Ekman M, Ericsson SR, Jonsson B, Glimelius B. Proton therapy of cancer: Potential clinical advantages and cost-effectiveness. Acta oncologica. 2005;44(8):850-61.
DOI
|
19 |
d'Errico F. NCRP Report no. 144-Radiation protection for particle accelerator facilities National Council on Radiation Protection and Measurements Issued 31 December 2003; revised 7 January 2005: NCRP, Bethesda, MD, USA ISBN: 0-929600-77-0, 499 pp, 100(Hardcover), 80 (electronic file downloadable from http://ncrppublications.org). Oxford University Press; 2005.
|
20 |
Ipe N, Fehrenbacher G, Gudowska I, Paganetti H, Schippers J, Roesler S. PTCOG publications sub-committee task group on shielding design and radiation safety of charged particle therapy facilities. PTCOG Report. 2010;1.
|
21 |
Harrabi S, Bougatf N, Mohr A, Haberer T, Herfarth K, Combs S, et al. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma. Strahlentherapie und Onkologie. 2016;192(11): 759-69.
DOI
|